Xenon Pharmaceuticals Inc.

Syed Abid Hasan

Christoph Martin Dehnhardt

Sultan Chowdhury

Thilo Focken

Michael Edward Grimwood

Kristen Nicole Burford

Alla Yurevna Zenova

Robert Joseph Devita

Jean-Christophe Andrez

James Philip Johnson, Jr

James Roy Empfield

Charles Jay Cohen

David Earl Bogucki

Qi Jia

Michael Scott Wilson

Shannon Marie Decker

James Philip Johnson

Jr Johnson James Philip

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.

Benzenesulfonamide compounds and their use as therapeutic agents

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.

Benzenesulfonamide compouds and their use as therapeutic agents

This invention is directed to methods of preparing benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.

Growing community of inventors

Vancouver, Canada

Syed Abid Hasan